Sign up to save your podcasts
Or
Share ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.
View all episodes
By ERS Publications Podcasts
3.8
44 ratings
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.
More shows like ERS Publications Podcasts
View all
JAMA Editors' Summary
139 Listeners
EMCrit FOAM Feed
1,868 Listeners
Thorax Podcast
1 Listeners
NEJM This Week
322 Listeners
Out of the Blue: An AJRCCM Podcast
36 Listeners
CHEST Journal Podcasts
63 Listeners
ATS Breathe Easy
36 Listeners
JAMA Clinical Reviews
500 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
BMJ Best Practice Podcast
26 Listeners
Core IM | Internal Medicine Podcast
1,137 Listeners
Annals On Call Podcast
192 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Critical Care Time
235 Listeners
The Respiratory Futures Podcast
1 Listeners